Cytokinetics (CYTK)
44.86 -1.14 (-2.48%) 10:00 ET [NASDAQ]
45.38 x 500 45.56 x 100
Realtime by (Cboe BZX)
45.38 x 500 45.56 x 100
Realtime 45.50 -0.50 (-1.09%) 06:50 ET
for Mon, Mar 3rd, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 94,857 | 113,024 | 65,582 | 112,666 | 82,985 |
| Marketable Securities | 981,157 | 501,800 | 716,995 | 358,972 | 381,075 |
| Receivables | 16,650 | 1,283 | 147 | 51,819 | 4,420 |
| TOTAL | $1,107,940 | $628,051 | $795,186 | $535,672 | $474,221 |
| Non-Current Assets | |||||
| PPE Net | 65,815 | 68,748 | 80,453 | 73,271 | 13,346 |
| Investments And Advances | 145,055 | 40,534 | 46,708 | 152,050 | 36,954 |
| Other Non-Current Assets | 82,863 | 86,983 | 92,428 | 80,326 | 9,282 |
| TOTAL | $293,733 | $196,265 | $219,589 | $305,647 | $59,582 |
| Total Assets | $1,401,673 | $824,316 | $1,014,775 | $841,319 | $533,803 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,520 | 10,080 | 958 | N/A | N/A |
| Accounts payable and accrued liabilities | 20,369 | 21,507 | 25,611 | 21,087 | 8,050 |
| Accrued Expenses | 55,323 | 42,641 | 44,096 | 34,370 | 19,315 |
| Other current liabilities | 21,114 | 10,559 | 1,123 | 1,540 | 1,049 |
| TOTAL | $179,674 | $102,678 | $84,617 | $71,860 | $31,199 |
| Non-Current Liabilities | |||||
| Long Term Debt | 93,227 | 58,384 | 63,810 | 47,367 | 46,209 |
| Deferred Revenues | 52,370 | N/A | N/A | N/A | N/A |
| aiOther Non-Current Liabilities | 1,264,144 | 1,049,577 | 974,248 | 391,229 | 256,012 |
| TOTAL | $1,357,371 | $1,107,961 | $1,038,058 | $525,596 | $389,221 |
| Total Liabilities | $1,537,045 | $1,210,639 | $1,122,675 | $597,456 | $420,420 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 103,005 | 95,161 | 84,856 | 71,111 |
| Common Shares | 118 | 102 | 94 | 84 | 70 |
| Retained earnings | -2,701,764 | -2,112,238 | -1,585,994 | -1,207,620 | -992,306 |
| Other shareholders' equity | 2,398 | -10 | -3,590 | -869 | 149 |
| TOTAL | $-135,372 | $-386,323 | $-107,900 | $243,863 | $113,383 |
| Total Liabilities And Equity | $1,401,673 | $824,316 | $1,014,775 | $841,319 | $533,803 |